Events

  Primary care has historically served as the backbone of our nation’s health care system, with patients often maintaining a relationship with a primary-care provider to guide their care over a period of years. Yet, the U.S. emphasizes primary care less than other high-income countries. And a shortage of primary-care…

    Nearly 1 in 5 consumers with health insurance say their insurer delayed or denied care in the past year due to its requirements for prior authorization, a process through which insurers can require patients to obtain approval in advance before they will agree to cover specific services. Insurers…

  Hear from caregivers about the costs and complexity of long-term care On Dec. 5, KFF Health News hosted a virtual conversation about “Dying Broke,” our joint investigation with The New York Times into America’s long-term care crisis and what can be done to mitigate its growing financial and emotional…

Amid low unemployment and rising demand for services, today’s health care workforce is under pressure from several directions, including worker strikes; shortages of trained staff; and proposed new staffing standards for nurses and aides in nursing facilities. On November 16, a panel of three experts joined Larry Levitt, executive vice…

Hear from National Medicaid Experts about Trends in Medicaid Finances, Key Policies and Challenges Beyond the Unwinding As states continue to manage the unwinding of the pandemic-related continuous enrollment provision of Medicaid and phase out of the enhanced federal matching funds, there is considerable uncertainty about how Medicaid enrollment and…

KFF held a web event on September 20, 2023 to discuss Medicare marketing practices in advance of the open enrollment period, which begins Oct. 15. As part of the event, KFF released a new analysis of television ads that aired during last year’s open enrollment season and share insights from…

The U.S. Food and Drug Administration recently approved Opill—the first over-the-counter daily oral contraceptive pill in the United States. Beginning in early 2024, people will be able to purchase Opill without a prescription, expanding options for contraceptive access across the country. While federal policy requires most private health insurance plans…

Watch an online conversation led by Céline Gounder, a physician-epidemiologist and the host of “Eradicating Smallpox,” Season 2 of the “Epidemic” podcast. The docuseries explores the parallels between the campaign to end a centuries-old disease and the challenges public health faces today. On Sept. 14, Gounder and her guests came…

With the Biden administration’s announcement of the first 10 drugs to be negotiated for Medicare as part of the Inflation Reduction Act (IRA), an array of legal challenges from the pharmaceutical industry is potentially the biggest obstacle to implementation. In court filings, individual drugmakers and the industry’s main lobbying group…

New weight loss drugs, such as Novo Nordisk’s Ozempic and Wegovy (semaglutide) and Eli Lilly’s Mounjaro (tirzepatide), could be transformative for people who struggle with obesity and obesity-related medical conditions, but there are major questions to consider related to insurance coverage, the cost of the drugs, and who has access.…